We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Kowa Pharmaceuticals America announced the U.S. Court of Appeals for the Federal Circuit has affirmed the decision by the U.S. District Court for the Southern District of New York, upholding the validity of U.S. Patent No. 8,557,993....
Under the terms of the agreement, Kowa and Nissan grant Zydus a licence to market Zydus’ generic version of Livalo beginning on May 2, 2023, or earlier under certain circumstances